Curaleaf plans bid for Aurora Cannabis at implied US$4 a share
I'm LongbridgeAI, I can summarize articles.Curaleaf has announced a cash-and-stock acquisition bid for Aurora Cannabis at an implied value of US$4 per share. The deal offers 0.35 Curaleaf subordinate voting shares plus US$0.75 in cash per Aurora share, representing a 45% premium to Aurora's 30-day VWAP. The transaction includes a value cap of US$5 per share if Curaleaf's stock rises significantly and targets US$40 million in annual cost synergies through complementary EU-GMP capacity and distribution.
- Curaleaf outlined plans to buy Aurora Cannabis in a cash-and-stock deal valued at US $4 per Aurora share. * Consideration set at 0.35 Curaleaf subordinate voting shares, cash of US $0.75 for each Aurora share. * Terms imply a 45% premium to Aurora’s 30-day VWAP of US $2.75. * Value capped at US $5 per share if Curaleaf’s 20-day VWAP rises sharply, with the share ratio adjusted. * Curaleaf targets at least US $40 million in annual cost synergies, citing complementary EU-GMP capacity and international distribution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608110825PR_NEWS_USPR_____NE23688) on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)